| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 82,862 | 76,418 | 143,545 | 214,113 | | Cost of Revenue | 18,818 | 19,808 | 23,037 | 25,312 | | | Gross Profit | 64,044 | 56,610 | 120,508 | 188,801 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (1,105) | 17,105 | 19,615 | 30,259 | | Non Recurring | 18,594 | 79,312 | 754,298 |
-
| | Others | 41,023 | 44,695 | 60,823 | 52,728 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,532 | (84,502) | (714,228) | 105,814 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,532 | (84,502) | (714,228) | 105,814 | | Interest Expense | 7,813 | 7,467 | 7,223 | 6,935 | | Income Before Tax | (2,281) | (91,969) | (721,451) | 98,879 | | Income Tax Expense | (71) | (32,966) | (268,970) | 36,608 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,210) | (59,003) | (452,481) | 62,271 | | | Non-recurring Events | | Discontinued Operations | (57) | (126) | (212) | (348) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,267) | (59,129) | (452,693) | 61,923 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,267) | ($59,129) | ($452,693) | $61,923 |
|
0.01% Nasdaq 0.00%
Income Statement
